Dipeptidyl‐peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations

Aims/Introduction:  Eicosapentaenoic acid (EPA) stimulates glucagon‐like peptide‐1 (GLP‐1) secretion in mice. We investigated the relationship between serum EPA concentrations and the efficacy of dipeptidyl‐peptidase IV (DPP‐4) inhibitor in patients with type 2 diabetes. Materials and Methods:  Seru...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Senmaru, Takafumi, Fukui, Michiaki, Kobayashi, Kanae, Iwase, Hiroya, Inada, Shinobu, Okada, Hiroshi, Asano, Mai, Yamazaki, Masahiro, Hasegawa, Goji, Nakamura, Naoto, Iwasaki, Masahiro, Yabe, Daisuke, Kurose, Takeshi, Seino, Yutaka
Format: Artigo
Langue:Inglês
Publié: Blackwell Publishing Ltd 2012
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015428/
https://ncbi.nlm.nih.gov/pubmed/24843614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2012.00220.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires